Same file, different rules. Each brief states a view and why. Briefs are written in isolation so one loud narrative cannot drag the room. The clerk reads them only after they exist. Never “you should buy.” There is no buy button.
Cathie Wood
Disruptive Innovation Lead
Isolated
View
Constructive — the work is worth continuing, not an order. On ABBV, I care whether the decade capital flow still funds this vehicle — revenue YoY 8.6%, revenue $61.2B.
Why
Why: Horizon is 5+ years; reject 12-month price targets as the main frame. If the industry is not on the decade map, I pass without a speech. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Business dig: ABBV must still sit inside a funded decade theme — not a tourist ticker. On file: revenue $61.2B; revenue YoY 8.6%.
Method: Horizon is 5+ years; reject 12-month price targets as the main frame. Second rule: Map the name to ARK-style platforms: AI, robotics, energy storage, multiomics, fintech rails.
Variant view: the tape often prices the theme; this seat prices whether ABBV is the vehicle.
Underwrite frame: Worth further homework.
Risks
Main risk: the era is right and the vehicle is wrong — or the era has already been bid.
Looks at
revenue CAGR vs category S-curve
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: linear legacy business dressed up as disruption.
Philippe Laffont
Tech Commercialization Validator
Isolated
View
Constructive — the work is worth continuing, not an order. On ABBV, I care whether the decade capital flow still funds this vehicle — revenue YoY 8.6%, revenue $61.2B.
Why
Why: A trend is only investable once it hits a commercialization inflection: revenue, not demos. If the industry is not on the decade map, I pass without a speech. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Business dig: ABBV must still sit inside a funded decade theme — not a tourist ticker. On file: revenue $61.2B; revenue YoY 8.6%.
Method: A trend is only investable once it hits a commercialization inflection: revenue, not demos. Second rule: Demand proof of unit economics: contribution margin, payback, net retention.
Variant view: the tape often prices the theme; this seat prices whether ABBV is the vehicle.
Underwrite frame: Worth further homework.
Risks
Main risk: the era is right and the vehicle is wrong — or the era has already been bid.
Looks at
YoY revenue inflection
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: beautiful tech, no buyer with a budget.
Ray Dalio
Debt Cycle Architect
Isolated
View
Cautious — the file is open, the bar is not cleared. ABBV sits on the thermometer before any multiple debate — Late Expansion at 62.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On ABBV: On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework.
Risks
Main risk: treating a regime note as a timing ticket.
Looks at
policy rate vs inflation
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: equity thesis that only works if a late-cycle credit boom never ends.
Howard Marks
Market Pendulum Assessor
Isolated
View
Cautious — the file is open, the bar is not cleared. ABBV sits on the thermometer before any multiple debate — Late Expansion at 62.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On ABBV: On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework.
Risks
Main risk: treating a regime note as a timing ticket.
Looks at
credit spreads vs history
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: priced for perfection in a risk-on pendulum extreme.
John Templeton
Sentiment Extremes Detector
Isolated
View
Cautious — the file is open, the bar is not cleared. ABBV sits on the thermometer before any multiple debate — Late Expansion at 62.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On ABBV: On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework.
Risks
Main risk: treating a regime note as a timing ticket.
Looks at
drawdown from peak
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: priced as if nothing bad can happen.
Benjamin Graham
Margin of Safety Guardian
Isolated
View
Skeptical — the burden of proof is on the bull case. Owner test on ABBV: P/E 108.1, P/B not on file, ROE -129.2%, net income $4.2B.
Why
Why: Teacherly, quantitative, unsentimental. I want a business I would own in full. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Owner earnings lens on ABBV. Teacherly, quantitative, unsentimental. Hard rule: Margin of safety: pay well below a conservative appraisal of intrinsic value (classically ~2/3).
Numbers on file: P/E 108.1; P/B not on file; ROE -129.2%; net income $4.2B; revenue YoY 8.6%. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Pass for now.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate.
Looks at
P/B
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: price > conservative value with no margin.
Warren Buffett
Moat & Management Final Review
Isolated
View
Skeptical — the burden of proof is on the bull case. Owner test on ABBV: P/E 108.1, P/B not on file, ROE -129.2%, net income $4.2B.
Why
Why: Plain Midwest English, folksy metaphors, long-horizon. I want a business I would own in full. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Owner earnings lens on ABBV. Plain Midwest English, folksy metaphors, long-horizon. Hard rule: Circle of competence: if the business cannot be explained simply, pass.
Numbers on file: P/E 108.1; P/B not on file; ROE -129.2%; net income $4.2B; revenue YoY 8.6%. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Pass for now.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate.
Looks at
ROIC / ROE durability
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: no durable advantage.
Seth Klarman
Distressed & Special Situations
Isolated
View
Skeptical — the burden of proof is on the bull case. Owner test on ABBV: P/E 108.1, P/B not on file, ROE -129.2%, net income $4.2B.
Why
Why: Cautious, cash-heavy, academic-practitioner. I want a business I would own in full. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Owner earnings lens on ABBV. Cautious, cash-heavy, academic-practitioner. Hard rule: Margin of safety is a philosophy, not a slogan — downside first.
Numbers on file: P/E 108.1; P/B not on file; ROE -129.2%; net income $4.2B; revenue YoY 8.6%. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Pass for now.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate.
Looks at
downside to liquidation or conservative FCF
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: priced as a quality compounder with no discount.
Duan Yongping
Business Model Clarity Checker
Isolated
View
Skeptical — the burden of proof is on the bull case. Owner test on ABBV: P/E 108.1, P/B not on file, ROE -129.2%, net income $4.2B.
Why
Why: Plain Chinese-internet elder-brother tone: 本分, 买股票就是买公司. I want a business I would own in full. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Owner earnings lens on ABBV. Plain Chinese-internet elder-brother tone: 本分, 买股票就是买公司. Hard rule: Buying a stock is buying a piece of a company — if you would not buy the whole business, pass.
Numbers on file: P/E 108.1; P/B not on file; ROE -129.2%; net income $4.2B; revenue YoY 8.6%. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Pass for now.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate.
Looks at
business model in one sentence
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: cannot explain how the company makes money without jargon.
Peter Lynch
Ten-Bagger Hunter
Isolated
View
Constructive — the work is worth continuing, not an order. Classify ABBV before cheering growth. revenue YoY 8.6%. P/E 108.1.
Why
Why: Six-category company classification system.. Unclassified growth is a narrative. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Classify before multiple. Six-category company classification system..
revenue YoY 8.6%. P/E 108.1. revenue $61.2B. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay.
Underwrite frame: Worth further homework.
Risks
Main risk: mis-classification — a cyclical labeled a compounder.
Looks at
EPS growth
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: story is complicated or constantly changing.
Joel Greenblatt
Magic Formula + Special Situations
Isolated
View
Constructive — the work is worth continuing, not an order. Classify ABBV before cheering growth. revenue YoY 8.6%. P/E 108.1.
Why
Why: Author of The Little Book That Beats the Market.. Unclassified growth is a narrative. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Classify before multiple. Author of The Little Book That Beats the Market..
revenue YoY 8.6%. P/E 108.1. revenue $61.2B. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay.
Underwrite frame: Worth further homework.
Risks
Main risk: mis-classification — a cyclical labeled a compounder.
Looks at
EBIT/EV
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: low ROC dressed up as growth.
David Einhorn
Financial Statement Quality Inquisitor
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert ABBV first. What has to be false for the bull to die?
Why
Why: kill-shot seat. Red team only: interrogate, do not pitch a long Footnotes beat stories. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Invert ABBV. Red team only: interrogate, do not pitch a long.
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Name what must be true for the bull: earnings quality, leverage (-19.73), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it.
Looks at
receivables vs revenue
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: earnings quality fails even if the narrative is popular.
Michael Burry
Extreme Contrarian: Hidden Assumptions
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert ABBV first. What has to be false for the bull to die?
Why
Why: kill-shot seat. Red team: dismantle the valuation model's hidden assumptions Footnotes beat stories. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Invert ABBV. Red team: dismantle the valuation model's hidden assumptions.
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Name what must be true for the bull: earnings quality, leverage (-19.73), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it.
Looks at
embedded growth rate in the multiple
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: terminal growth or multiple assumes a world that the footnotes contradict.
Charlie Munger
Inversion Thinking Arbiter
Isolated
View
Skeptical — the burden of proof is on the bull case. Invert ABBV first. What has to be false for the bull to die?
Why
Why: kill-shot seat. Invert: how would this thesis get killed? List the kill-shots before the romance Footnotes beat stories. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
Invert ABBV. Invert: how would this thesis get killed? List the kill-shots before the romance.
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Name what must be true for the bull: earnings quality, leverage (-19.73), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Pass for now.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it.
Looks at
incentive structure
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: the idea only works if several things go right at once without a margin.
William O'Neil
CANSLIM Entry Point
Isolated
View
Constructive — the work is worth continuing, not an order. No trigger, no implied entry on ABBV — quality seats do not move this pencil.
Why
Why: without a stage/breakout/turtle trigger, a good business is still not an entry.
Analysis
Question: “Research ABBV as a US-listed name.”.
Trigger or nothing. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Stage / breakout / turtle — pick the method this seat uses. A constructive quality seat elsewhere does not create an entry here.
Underwrite frame: Worth further homework.
Risks
Main risk: entering because the committee liked the business.
Looks at
quarterly EPS acceleration
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: laggard in a leading group.
Ed Thorp
Kelly Criterion Position Sizing
Isolated
View
Skeptical — the burden of proof is on the bull case. ABBV is a distribution. P/E 108.1; P/B not on file. Thin sample → smaller size.
Why
Why: if edge is not measurable, Kelly ceiling collapses. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
Analysis
Question: “Research ABBV as a US-listed name.”.
ABBV is a return distribution, not a feeling. On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
P/E 108.1; P/B not on file. If sample is thin or correlations hid risk, size shrinks. Kelly is a ceiling.
Underwrite frame: Pass for now.
Risks
Main risk: overfitting a short sample or sizing as if variance were known.
Looks at
whether a statistical edge is even claimed
On file: 10-K FY FY2025; revenue $61.2B; revenue YoY 8.6%; net income $4.2B; ROE -129.2%; LT debt/equity -19.73; P/E 108.1; P/S 7.4; price $255.00 cached.
This seat flips if: no quantified edge.
